Low-dose captopril: its use in mild to moderate hypertension unresponsive to diuretic treatment
- PMID: 6284081
- DOI: 10.1001/archinte.142.6.1098
Low-dose captopril: its use in mild to moderate hypertension unresponsive to diuretic treatment
Abstract
The effect of low doses (25 mg three times a day) of captopril was evaluated in 16 patients with mild to moderate essential hypertension, previously uncontrolled by hydrochlorothiazide. After a no-treatment period, mean eight-hour seated diastolic blood pressure (SDBP, mm Hg) was 103 +/- 5 on placebo, 95 +/- 8 after a single dose of captopril, 96 +/- 4 after two weeks of captopril alone, and 90 +/- 6 after its combination with hydrochlorothiazide. Though nine patients had at least a 10% fall in SDBP after the initial dose of captopril, only three had a comparable fall after two weeks; after captopril and hydrochlorothiazide, however, 12 patients had such a response. Captopril decreased mean angiotensin-converting enzyme activity and plasma aldosterone, though to a lesser extent with continued therapy. Because its side effects appear dose related, low doses of captopril combined with a diuretic are effective and may be better tolerated.
Similar articles
-
Comparison of captopril and hydrochlorothiazide alone and in combination in mild to moderate essential hypertension.Br J Clin Pharmacol. 1982;14 Suppl 2(Suppl 2):127S-131S. doi: 10.1111/j.1365-2125.1982.tb02069.x. Br J Clin Pharmacol. 1982. PMID: 6753893 Free PMC article. Clinical Trial.
-
Captopril in essential hypertension; contrasting effects of adding hydrochlorothiazide or propranolol.Br Med J (Clin Res Ed). 1982 Mar 6;284(6317):693-6. doi: 10.1136/bmj.284.6317.693. Br Med J (Clin Res Ed). 1982. PMID: 6802291 Free PMC article. Clinical Trial.
-
Racial differences in response to low-dose captopril are abolished by the addition of hydrochlorothiazide.Br J Clin Pharmacol. 1982;14 Suppl 2(Suppl 2):97S-101S. Br J Clin Pharmacol. 1982. PMID: 6753911 Free PMC article. Clinical Trial.
-
Hormonal changes with long-term converting-enzyme inhibition by captopril in essential hypertension.Clin Sci (Lond). 1979 Dec;57 Suppl 5:135s-138s. doi: 10.1042/cs057135s. Clin Sci (Lond). 1979. PMID: 232017 Clinical Trial.
-
The effect of captopril on renal hemodynamics in hypertensive patients.J Clin Pharmacol. 1984 Aug-Sep;24(8-9):351-9. doi: 10.1002/j.1552-4604.1984.tb02787.x. J Clin Pharmacol. 1984. PMID: 6384279
Cited by
-
Low dose combination antihypertensive therapy. Additional efficacy without additional adverse effects?Drug Saf. 1995 Feb;12(2):85-90. doi: 10.2165/00002018-199512020-00001. Drug Saf. 1995. PMID: 7766339 Review. No abstract available.
-
Captopril. An update of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and congestive heart failure.Drugs. 1988 Nov;36(5):540-600. doi: 10.2165/00003495-198836050-00003. Drugs. 1988. PMID: 3063499 Review.
-
Angiotensin converting enzyme inhibitors and moderate hypertension.Drugs. 1990 Sep;40(3):326-45. doi: 10.2165/00003495-199040030-00002. Drugs. 1990. PMID: 2226219 Review.
-
Enalapril in essential hypertension.Drugs. 1985;30 Suppl 1:35-46. doi: 10.2165/00003495-198500301-00006. Drugs. 1985. PMID: 2994986
-
Effect of captopril and hydrochlorothiazide on the response to pressor agents in hypertensives.Eur J Clin Pharmacol. 1985;28(1):5-9. doi: 10.1007/BF00635700. Eur J Clin Pharmacol. 1985. PMID: 3886401 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical